We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biotechs Lead Wave Of New IPOs Filling June Pipeline

Law360 (May 25, 2018, 7:48 PM EDT) -- A wave of venture-backed biotechnology and health care companies are lining up initial public offerings that could price in June, including at least eight that filed plans during the week of May 21, leading more than a dozen IPO prospects set to reignite deal flow in the coming weeks.

Eidos Therapeutics Inc. and Avrobio Inc., which are developing therapies to treat rare diseases, filed IPOs on Friday that are estimated to raise $115 million and $86 million, respectively. Both companies are represented by Goodwin Procter LLP....
To view the full article, register now.